butorphanol has been researched along with carisoprodol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Finch, MD; Haddox, JD; Kim, SS; Parente, ST; Rector, TS; Schloff, LA; Seifeldin, R | 1 |
1 review(s) available for butorphanol and carisoprodol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for butorphanol and carisoprodol
| Article | Year |
|---|---|
Identifying controlled substance patterns of utilization requiring evaluation using administrative claims data.
Topics: Adolescent; Adult; Analgesics, Opioid; Benzodiazepines; Butorphanol; Carisoprodol; Clinical Pharmacy Information Systems; Contraindications; Databases as Topic; Drug and Narcotic Control; Drug Prescriptions; Drug Utilization Review; Humans; Insurance Claim Review; Managed Care Programs; Middle Aged; Pain; Pattern Recognition, Automated; Prevalence; Substance-Related Disorders; United States | 2004 |